Can a pill slow aging? small trial tests sirolimus in seniors
NCT ID NCT05237687
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 2 trial is testing whether the drug sirolimus can slow aging in adults aged 65 to 80. Ten participants will be randomly assigned to receive sirolimus or standard care, and researchers will measure aging biomarkers like walking speed and cellular changes after one year. The goal is to see if sirolimus can reduce age-related decline and prevent chronic diseases.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Sirolimus (a drug that may slow aging at the cellular level)
What this could lead to
If it works, this could point toward a treatment that delays aging and reduces chronic diseases like skin cancer.
What could go wrong
This is a very small early-phase trial with only 10 participants, so results may not apply to everyone. Sirolimus is an immunosuppressant and can have side effects like increased infection risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UT Southwestern Medical Center
RECRUITINGDallas, Texas, 75390, United States
Contact